2008 JASN IMPACT FACTOR 7.505	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by KASISKE, B. L. Articles by ROEL, J. Search for Related Content PubMed PubMed Citation Articles by KASISKE, B. L. Articles by ROEL, J.

Explained and Unexplained Ischemic Heart Disease Risk after Renal Transplantation

Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota.

Correspondence to Dr. Bertram L. Kasiske, Department of Medicine, Hennepin County Medical Center, 701 Park Avenue South, Minneapolis, MN 55415. Phone: 612-347-6088: Fax: 612-347-2003; E-mail: kasis001{at}tc.umn.edu

Abstract. Whether the high incidence of ischemic heart disease (IHD) among renal transplant patients can be attributed to the same risk factors that have been identified in the general population is unclear. The risk for major IHD events occurring >1 yr after transplantation among 1124 transplant recipients was estimated by using the risk calculated from the Framingham Heart Study (FHS). The FHS risk predicted IHD (relative risk, 1.28; 95% confidence interval, 1.20 to 1.40; P < 0.001); however, the FHS risk tended to underestimate the risk of IHD for renal transplant recipients. This was largely attributable to increased risks associated with diabetes mellitus and, to a lesser extent, age and cigarette smoking for renal transplant recipients. For men, the relative risks for diabetes mellitus were 2.78 (1.73 to 4.49) and 1.53 for the transplant recipient and FHS populations, respectively; the relative risks for age (in years) were 1.06 (1.04 to 1.08) and 1.05, respectively, and those for smoking were 1.95 (1.20 to 3.19) and 1.69, respectively. For women, the relative risks for diabetes mellitus were 5.40 (2.73 to 10.66) and 1.82, respectively. There was a tendency for the risk associated with cholesterol levels to be higher for transplant recipients, compared with the FHS population, but the risks associated with high-density lipoprotein cholesterol levels and BP appeared to be comparable. Independent of these and other risk factors, the adjusted risk of IHD for the transplant recipient population has decreased. Compared with the era before 1986, transplantation between 1986 and 1992 was associated with a lower relative risk of 0.60 (0.39 to 0.92); transplantation after 1992 was associated with an even lower relative risk of 0.27 (0.11 to 0.63) for IHD. Of concern was the fact that dihydropyridine calcium channel antagonists were associated with an increased risk for IHD (relative risk, 2.26; 95% confidence interval, 1.24 to 4.12; P = 0.008), and this association was independent of other antihypertensive agents and risk factors. Therefore, although the FHS risk predicts IHD after renal transplantation, it tends to underestimate the risks, especially the risk associated with diabetes mellitus. The unexpected finding that dihydropyridine calcium channel antagonists were associated with an increased IHD risk merits further evaluation.

This article has been cited by other articles:

				F. Wiesbauer, G. Heinze, C. Mitterbauer, F. Harnoncourt, W. H. Horl, and R. Oberbauer Statin Use Is Associated with Prolonged Survival of Renal Transplant Recipients J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2211 - 2218. [Abstract] [Full Text] [PDF]

				H. W. Chan, C. Y. Cheung, Y. L. Liu, Y. H. Chan, H. S. Wong, W. L. Chak, K. S. Choi, K. F. Chau, and C. S. Li Prevalence of abnormal glucose metabolism in Chinese renal transplant recipients: a single centre study Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3337 - 3342. [Abstract] [Full Text] [PDF]

				D. R. J. Kuypers, K. Claes, B. Bammens, P. Evenepoel, and Y. Vanrenterghem Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM) Nephrol. Dial. Transplant., June 1, 2008; 23(6): 2033 - 2042. [Abstract] [Full Text] [PDF]

				B. Kiberd and R. Panek Cardiovascular Outcomes in the Outpatient Kidney Transplant Clinic: The Framingham Risk Score Revisited Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 822 - 828. [Abstract] [Full Text] [PDF]

				G. M. Connolly, R. Cunningham, P. T. McNamee, I. S. Young, and A. P. Maxwell Troponin T is an independent predictor of mortality in renal transplant recipients Nephrol. Dial. Transplant., March 1, 2008; 23(3): 1019 - 1025. [Abstract] [Full Text] [PDF]

				A. C. Shirali and M. J. Bia Management of Cardiovascular Disease in Renal Transplant Recipients Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 491 - 504. [Abstract] [Full Text] [PDF]

				B. Edemir, S. Reuter, R. Borgulya, R. Schroter, U. Neugebauer, G. Gabriels, and E. Schlatter Acute Rejection Modulates Gene Expression in the Collecting Duct J. Am. Soc. Nephrol., March 1, 2008; 19(3): 538 - 546. [Abstract] [Full Text] [PDF]

				J. S. Gill Cardiovascular Disease in Transplant Recipients: Current and Future Treatment Strategies Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(Supplement_2): S29 - S37. [Abstract] [Full Text] [PDF]

				F. Verbeke, W. Van Biesen, P. Peeters, L. M. Van Bortel, and R. C. Vanholder Arterial stiffness and wave reflections in renal transplant recipients Nephrol. Dial. Transplant., October 1, 2007; 22(10): 3021 - 3027. [Abstract] [Full Text] [PDF]

				S. M. Vigano, M. Turiel, V. Martina, E. Meregalli, L. Tomasoni, G. De Blasio, L. Delfino, A. Edefonti, P. Grillo, M. Procaccio, et al. Reduced coronary flow reserve in young adults with renal transplant Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2328 - 2333. [Abstract] [Full Text] [PDF]

				D. E. Weiner, H. Tighiouart, E. F. Elsayed, J. L. Griffith, D. N. Salem, A. S. Levey, and M. J. Sarnak The Framingham Predictive Instrument in Chronic Kidney Disease J. Am. Coll. Cardiol., July 17, 2007; 50(3): 217 - 224. [Abstract] [Full Text] [PDF]

				M. F. Crutchlow and R. D. Bloom Transplant-Associated Hyperglycemia: A New Look at an Old Problem Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 343 - 355. [Abstract] [Full Text] [PDF]

				R. Marcen, J. M. Morales, M. Arias, G. Fernandez-Juarez, G. Fernandez-Fresnedo, A. Andres, E. Rodrigo, J. Pascual, B. Dominguez, and J. Ortuno Ischemic Heart Disease after Renal Transplantation in Patients on Cyclosporine in Spain J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S286 - S290. [Abstract] [Full Text] [PDF]

				I. Soveri, H. Holdaas, A. Jardine, C. Gimpelewicz, B. Staffler, and B. Fellstrom Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2282 - 2289. [Abstract] [Full Text] [PDF]

				B. L. Kasiske, J. R. Maclean, and J. J. Snyder Acute Myocardial Infarction and Kidney Transplantation J. Am. Soc. Nephrol., March 1, 2006; 17(3): 900 - 907. [Abstract] [Full Text] [PDF]

				J. S. Gill, I. Ma, D. Landsberg, N. Johnson, and A. Levin Cardiovascular Events and Investigation in Patients Who Are Awaiting Cadaveric Kidney Transplantation J. Am. Soc. Nephrol., March 1, 2005; 16(3): 808 - 816. [Abstract] [Full Text] [PDF]

				K. L. Lentine, D. C. Brennan, and M. A. Schnitzler Incidence and Predictors of Myocardial Infarction after Kidney Transplantation J. Am. Soc. Nephrol., February 1, 2005; 16(2): 496 - 506. [Abstract] [Full Text] [PDF]

				J. A Davidson and A. Wilkinson New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: An endocrinologist's view Diabetes Care, March 1, 2004; 27(3): 805 - 812. [Full Text] [PDF]

				M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Hypertension, November 1, 2003; 42(5): 1050 - 1065. [Full Text] [PDF]

				M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation, October 28, 2003; 108(17): 2154 - 2169. [Full Text] [PDF]

				K. C. Abbott, C. M. Yuan, A. J. Taylor, D. F. Cruess, and L. Y. C. Agodoa Early Renal Insufficiency and Hospitalized Heart Disease after Renal Transplantation in the Era of Modern Immunosuppression J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2358 - 2365. [Abstract] [Full Text] [PDF]

				D. Ducloux, B. Challier, P. Saas, P. Tiberghien, and J.-M. Chalopin CD4 Cell Lymphopenia and Atherosclerosis in Renal Transplant Recipients J. Am. Soc. Nephrol., March 1, 2003; 14(3): 767 - 772. [Abstract] [Full Text] [PDF]

				K. C. Abbott, J. R. Bucci, D. Cruess, A. J. Taylor, and L. Y.C. Agodoa Graft Loss and Acute Coronary Syndromes after Renal Transplantation in the United States J. Am. Soc. Nephrol., October 1, 2002; 13(10): 2560 - 2569. [Abstract] [Full Text] [PDF]

				D. Goldsmith, R. MacGinley, A. Smith, and A. Covic How important and how treatable is vascular stiffness as a cardiovascular risk factor in renal failure? Nephrol. Dial. Transplant., June 1, 2002; 17(6): 965 - 969. [Full Text] [PDF]

				C. Rigatto, P. Parfrey, R. Foley, C. Negrijn, C. Tribula, and J. Jeffery Congestive Heart Failure in Renal Transplant Recipients: Risk Factors, Outcomes, and Relationship with Ischemic Heart Disease J. Am. Soc. Nephrol., April 1, 2002; 13(4): 1084 - 1090. [Abstract] [Full Text] [PDF]

				M. Pascual, T. Theruvath, T. Kawai, N. Tolkoff-Rubin, and A. B. Cosimi Strategies to Improve Long-Term Outcomes after Renal Transplantation N. Engl. J. Med., February 21, 2002; 346(8): 580 - 590. [Full Text] [PDF]

				A. G Jardine and K. McLaughlin GENERAL CARDIOLOGY: Cardiovascular complications of renal disease Heart, October 1, 2001; 86(4): 459 - 466. [Full Text] [PDF]

				A. G. Bostom, J. Selhub, P. F. Jacques, and I. H. Rosenberg Power Shortage: Clinical Trials Testing the "Homocysteine Hypothesis" against a Background of Folic Acid-Fortified Cereal Grain Flour Ann Intern Med, July 17, 2001; 135(2): 133 - 137. [Abstract] [Full Text] [PDF]

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673